News

Robitussin taps Peggy Fleming for new campaign

BY Allison Cerra

MADISON, N.J. — Robitussin has launched a new campaign in line with the start of the cold and flu season called the Simple Acts of Relief program.

As part of the program, Robitussin has tapped Olympic medalist Peggy Fleming for its Last Names Giveaway. Through the Last Names Giveaway, the brand is making an exclusive offer to people whose last name is (or sounds like) one of the cold symptoms Robitussin treats. The first 5,000 eligible entrants, which can submit their names at SimpleActsofRelief.com, will receive free Robitussin to help get them through this cold and flu season, the company said.

In addition to the Last Names Giveaway, the Simple Acts of Relief program also includes an instant win game, a sweepstakes that includes a grand prize of $100,000, and a mobile tour, where Robitussin will visit cities across the nation to provide cold sufferers with a "simple act of relief," such as a refreshment, a warm scarf or a coupon towards Robitussin.

For more information, visit SimpleActsofRelief.com.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Winn-Dixie announces intradermal flu vaccine availability at pharmacies

BY Allison Cerra

JACKSONVILLE, Fla. — Winn-Dixie has expanded its flu shot options by offering the Fluzone Intradermal vaccination at its in-store pharmacies.

The intradermal vaccine is available for guests at the discounted rate of $29.99 when purchased using their Winn-Dixie customer reward card, the supermarket chain said. The vaccination, which is administered just below the skin with a microneedle that is 90% smaller than regular needles, is approved for customers ages 18 to 64 years. Winn-Dixie said the flu shot option is in addition to the regular flu shot, approved for people ages 3 years and older, and a high-dose flu shot, approved and recommended for people ages 65 years and older, that it offers to customers.

Certain age restrictions may apply in some states regarding pharmacist administration of vaccinations, Winn-Dixie noted.

“We are constantly looking for ways to meet and exceed our guests’ expectations and offering a variety of administrations for the seasonal flu vaccine is just another way for us to properly serve our guests,” Winn-Dixie VP pharmacy John Fegan said. “Our guests’ health and wellness is our primary concern, and being at the forefront with new innovations helps us to provide these services to our neighborhoods.”


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Heather Bresch promoted to CEO at Mylan

BY Allison Cerra

PITTSBURGH — Generic drug maker Mylan’s board of directors has approved a new management structure for the company, effective Jan. 1, 2012.

Mylan’s board approved the transition of current chairman and CEO Robert Coury to the new role of executive board chairman. With this, Mylan president Heather Bresch will become CEO and directly report to the company’s board.

Replacing Bresch as president is Mylan COO Rajiv Malik, while the generic drug maker’s current president of North America operations, Harry "Hal" Korman, will be promoted to COO. Replacing Korman will be Tony Mauro. Mauro, who serves as president of Mylan Pharmaceuticals, will retain his current role in addition to his new role as president of North America operations.

Coury, Bresch, Malik, Korman and Mauro have agreed to new, 3-year contracts in conjunction with these leadership changes, Mylan said.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?